1. Home
  2. STTK vs SPIR Comparison

STTK vs SPIR Comparison

Compare STTK & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.95

Market Cap

459.4M

Sector

Health Care

ML Signal

HOLD

Logo Spire Global Inc.

SPIR

Spire Global Inc.

HOLD

Current Price

$21.20

Market Cap

533.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
SPIR
Founded
2016
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
459.4M
533.0M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
STTK
SPIR
Price
$6.95
$21.20
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$7.60
$14.20
AVG Volume (30 Days)
502.9K
1.4M
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
53.02
134.98
EPS
N/A
1.49
Revenue
$1,000,000.00
$110,451,000.00
Revenue This Year
N/A
$11.91
Revenue Next Year
N/A
$23.34
P/E Ratio
N/A
$12.02
Revenue Growth
N/A
13.15
52 Week Low
$0.71
$6.60
52 Week High
$7.68
$20.51

Technical Indicators

Market Signals
Indicator
STTK
SPIR
Relative Strength Index (RSI) 65.29 73.88
Support Level $5.75 $8.05
Resistance Level N/A N/A
Average True Range (ATR) 0.47 1.78
MACD 0.03 0.77
Stochastic Oscillator 61.66 97.25

Price Performance

Historical Comparison
STTK
SPIR

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About SPIR Spire Global Inc.

Spire Global Inc provides space-based data, analytics, and space services, offering datasets and insights about Earth to support decision-making. It builds, owns, and operates a constellation of nanosatellites that observe the Earth in real time using radio frequency (RF) technology. Additionally, it offers Space Services solutions that allow customers to deploy and scale their own satellite constellations using its platform, ground station network, manufacturing facilities, and launch partnerships. The company derives revenue from providing data, insights and access to its cloud-based technology platform sold on a subscription basis.

Share on Social Networks: